Generation, characterization, and use of monoclonal antibodies against parathyroid hypertensive factor

Clinical Chemistry

Volumn 49, Issue 7, 2003, Pages 1204-1206

  Krylova, Svetlana ^a   Labedz, Teresa ^b   Lewanczuk, Richard Z ^b   Benishin, Christina G ^b  

^a CV Technologies Inc   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; MONOCLONAL ANTIBODY; PARATHYROID HYPERTENSIVE FACTOR; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ARTICLE; BIOASSAY; BLOOD LEVEL; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CELL CLONING; CELL CULTURE; CELL LINE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; CROSS REACTION; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYBRIDOMA; HYPERTENSION; INTERMETHOD COMPARISON; MALE; MICROTITER PLATE ASSAY; MOUSE; MYELOMA CELL; NONHUMAN; PARATHYROID GLAND; PATIENT SELECTION; QUANTITATIVE ANALYSIS; RELIABILITY; SPLEEN CELL; SUPERNATANT;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CELL LINE; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; RATS;

ANIMALIA;

EID: 0037596723     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.7.1204     Document Type: Article

References (14)

1. Lewanczuk RZ, Resnick LM, Blumenfeld JD, Laragh JH, Pang PK. A new circulating hypertensive factor in the plasma of essential hypertensive subjects. J Hypertens 1990;8:105-8.
2. Lewanczuk RZ, Pang PK. Parathyroid hypertensive factor is present in DOCA-salt but not two-kidney-one-clip hypertensive rats. Am J Hypertens 1991;4:802-5.
3. Lewanczuk RZ, Pang PK. The occurrence of parathyroid hypertensive factor (PHF) in Dahl rats. Am J Hypertens 1993;6:758-62.
4. Shan J, Benishin CG, Lewanczuk RZ, Pang PK. Mechanism of the vascular action of parathyroid hypertensive factor. J Cardiovasc Pharmacol 1994;23:S1-8.
5. + channels in vascular smooth muscle cells. Can J Physiol Pharmacol 1999;77:860-5.
6. Lewanczuk RZ, Pang PKT. In vivo potentiation of vasopressors by spontaneously hypertensive rat plasma: correlation with blood pressure and calcium uptake. Clin Exp Hypertens 1989;A11:1471-85.
7. Lewanczuk RZ, Hamilton PG. Parathyroid hypertensive factor predicts efficacy in the treatment of essential hypertension with verapamil. Blood Press 1996;5:98-104.
8. Krylova SM, Pang PKT, Shan J, Lewanczuk RZ, Benishin CG. Quantitative determination of parathyroid hypertensive factor by enzyme-linked immunosorbent assay. Am J Hypertens 2000;13:1173-9.
9. Benishin CG, Lewanczuk RZ, Shan JJ, Pang PK. Parathyroid hypertensive factor secretion from subcultured spontaneously hypertensive rat parathyroid cells. Am J Hypertens 1999;12:1260-3.
10. Benishin CG, Tang L, Lewanczuk RZ, Pang PK. Production of polyclonal antisera to parathyroid hypertensive factor from spontaneously hypertensive rats. J Hypertens 1993;11:245-51.
11. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988:196-237.
12. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988:78-81.
13. Lewanczuk RZ, Wang J, Zhang ZR, Pang PKT. Effects of spontaneously hypertensive rat plasma on blood pressure and tail artery calcium uptake in normotensive rats. Am J Hypertens 1989;2:26-31.
14. Ho MS, Lewanczuk RZ, Teh BH, Lee SC, Pang PK. Parathyroid hypertensive factor and non-insulin-dependent diabetes mellitus. J Cardiovasc Pharmacol 1994;23:S31-4.